225 related articles for article (PubMed ID: 12108434)
1. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002.
Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434
[No Abstract] [Full Text] [Related]
2. Abstracts of the 13th International Congress on Cardiovascular Pharmacotherapy. November 29-December 2, 2007. Antalya, Turkey.
Remme WJ
Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1(1):S6-43. PubMed ID: 17963033
[No Abstract] [Full Text] [Related]
3. Abstracts of the 10th International Congress on Cardiovascular Pharmacotherapy. Kyoto, Japan, 27-31 March 2001.
Cardiovasc Drugs Ther; 2001 Mar; 15 Suppl 1():1-166. PubMed ID: 11501560
[No Abstract] [Full Text] [Related]
4. 7th International Symposium on Cardiovascular Pharmacotherapy. Jerusalem, Israel, June 1-5, 1997. Abstracts.
Cardiovasc Drugs Ther; 1997 Jun; 11 Suppl 2():315-421. PubMed ID: 9255319
[No Abstract] [Full Text] [Related]
5. The importance of drug discovery for treatment of cardiovascular diseases.
Kennedy C
Future Med Chem; 2013 Mar; 5(4):355-7. PubMed ID: 23495678
[No Abstract] [Full Text] [Related]
6. Abstracts of the 12th International Congress on Cardiovascular Pharmacotherapy. May 7-10, 2003. Barcelona, Spain.
Cardiovasc Drugs Ther; 2003; 17(5-6):481-504. PubMed ID: 15318397
[No Abstract] [Full Text] [Related]
7. Investigation of vascular mechanisms: bridging the gap between basic research and clinical trials.
Collier J; Vallance P
Trends Pharmacol Sci; 1993 Jul; 14(7):257-8. PubMed ID: 8212320
[No Abstract] [Full Text] [Related]
8. 8th International Symposium on Cardiovascular Pharmacotherapy. Amsterdam, The Netherlands. March 28 April 1, 1999. Abstracts.
Cardiovasc Drugs Ther; 1999 Mar; 13(1):1-86. PubMed ID: 10405623
[No Abstract] [Full Text] [Related]
9. Epicardial fat: a new cardiovascular therapeutic target.
Iacobellis G
Curr Opin Pharmacol; 2016 Apr; 27():13-8. PubMed ID: 26848943
[TBL] [Abstract][Full Text] [Related]
10. The Future of Cardiovascular Therapeutics.
MacRae CA; Roden DM; Loscalzo J
Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
[No Abstract] [Full Text] [Related]
11. 5th International Symposium on Cardiovascular Pharmacotherapy. August 16-20, 1993. Abstracts.
Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 2():397-478. PubMed ID: 8105879
[No Abstract] [Full Text] [Related]
12. Influence of sex on cardiovascular drug responses: role of estrogen.
Abdel-Rahman AA
Curr Opin Pharmacol; 2017 Apr; 33():1-5. PubMed ID: 28340373
[TBL] [Abstract][Full Text] [Related]
13. 9th International Congress on Cardiovascular Pharmacotherapy. Salvador, Bahia, Brazil, March 26-30, 2000. Abstracts.
Cardiovasc Drugs Ther; 2000 Mar; 14(2):117-234. PubMed ID: 10907050
[No Abstract] [Full Text] [Related]
14. Cardiovascular receptors as drug targets. Eur omega Conferences' Cardiovascular receptors as drug targets. Institut Pasteur, Paris, France, 3-4 October 1996.
Maack T
Mol Med Today; 1997 Mar; 3(3):101-2. PubMed ID: 9095483
[No Abstract] [Full Text] [Related]
15. Therapeutic potential of neuregulin-1 in cardiovascular disease.
Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
[TBL] [Abstract][Full Text] [Related]
16. The application of phenotypic high-throughput screening techniques to cardiovascular research.
Etzion Y; Muslin AJ
Trends Cardiovasc Med; 2009 Aug; 19(6):207-12. PubMed ID: 20211437
[TBL] [Abstract][Full Text] [Related]
17. Organs-on-chip models for cardiovascular drug development.
Zimmermann WH
Cardiovasc Res; 2021 Nov; 117(12):e164-e165. PubMed ID: 34347045
[No Abstract] [Full Text] [Related]
18. Leptin and the cardiovascular system - a target for therapeutic interventions.
Beltowski J
Curr Pharm Des; 2014; 20(4):601-2. PubMed ID: 23688018
[No Abstract] [Full Text] [Related]
19. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
Roden DM
Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular pharmacology (V). Pharmacological interactions in the patient on immunodepressant treatment].
Alonso Pulpón L; Anguita Sánchez M
Rev Esp Cardiol; 1994 Oct; 47(10):687-98. PubMed ID: 7991923
[No Abstract] [Full Text] [Related]
[Next] [New Search]